Healthcare provider profile · identity verified

Nelson Ivan Sanchez, MD

Internal Medicine · LOS ANGELES, CA · NPI 1861569600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	669	244
Losartan Potassium	Losartan Potassium	572	186
Rosuvastatin Calcium	Rosuvastatin Calcium	427	166
Amlodipine Besylate	Amlodipine Besylate	355	128
Omeprazole	Omeprazole	284	122
Metformin Hcl	Metformin Hcl	259	94
Glipizide	Glipizide	253	90
Levothyroxine Sodium	Levothyroxine Sodium	212	72
Lisinopril	Lisinopril	209	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	41
Pantoprazole Sodium	Pantoprazole Sodium	189	70
Albuterol Sulfate Hfa	Albuterol Sulfate	180	77
Hydrochlorothiazide	Hydrochlorothiazide	162	56
Metoprolol Tartrate	Metoprolol Tartrate	157	57
Trazodone Hcl	Trazodone Hcl	157	69
Tamsulosin Hcl	Tamsulosin Hcl	153	63
Ibuprofen	Ibuprofen	148	52
Metformin Hcl Er	Metformin Hcl	128	56
Alprazolam	Alprazolam	121	14
Gabapentin	Gabapentin	117	48
Simvastatin	Simvastatin	116	38
Atenolol	Atenolol	115	40
Terazosin Hcl	Terazosin Hcl	114	42
Lorazepam	Lorazepam	113	37
Tramadol Hcl	Tramadol Hcl	112	24
Alendronate Sodium	Alendronate Sodium	109	41
Furosemide	Furosemide	108	45
Azelastine Hcl	Azelastine Hcl	103	57
Meloxicam	Meloxicam	100	60
Ozempic	Semaglutide	98	13
Pradaxa	Dabigatran Etexilate Mesylate	96	27
Glipizide-Metformin	Glipizide/Metformin Hcl	92	32
Humulin N	Insulin Nph Human Isophane	91	30
Triamcinolone Acetonide	Triamcinolone Acetonide	89	53
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	30
Bisoprolol Fumarate	Bisoprolol Fumarate	80	26
Potassium Chloride	Potassium Chloride	79	34
Famotidine	Famotidine	78	32
Finasteride	Finasteride	77	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	26
Temazepam	Temazepam	75	13
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	71	27
Prednisone	Prednisone	69	54
Sertraline Hcl	Sertraline Hcl	69	27
Jardiance	Empagliflozin	67	29
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	67	33
Duloxetine Hcl	Duloxetine Hcl	62	33
Nabumetone	Nabumetone	62	28
Zolpidem Tartrate	Zolpidem Tartrate	61	suppressed
Azithromycin	Azithromycin	54	42
Estradiol	Estradiol	52	23
Ipratropium Bromide	Ipratropium Bromide	52	38
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	36
Clopidogrel	Clopidogrel Bisulfate	49	16
Mirtazapine	Mirtazapine	48	25
Montelukast Sodium	Montelukast Sodium	46	22
Allopurinol	Allopurinol	45	17
Lactulose	Lactulose	45	26
Ondansetron Odt	Ondansetron	45	26
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	43	43
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	43	13
Pregabalin	Pregabalin	40	suppressed
Clobetasol Propionate	Clobetasol Propionate	38	21
Ezetimibe	Ezetimibe	38	14
Carvedilol	Carvedilol	37	12
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	37	14
Humulin N Kwikpen	Insulin Nph Human Isophane	36	12
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	35	29
Spironolactone	Spironolactone	34	17
Humulin R	Insulin Regular, Human	33	11
Fenofibrate	Fenofibrate	32	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	32	32
Pioglitazone Hcl	Pioglitazone Hcl	32	15
Hydralazine Hcl	Hydralazine Hcl	30	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	29	29
Cephalexin	Cephalexin	29	22
Fluticasone Propionate	Fluticasone Propionate	29	13
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	29	12
Ciclopirox	Ciclopirox	28	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	12
Levetiracetam	Levetiracetam	28	suppressed
Lovastatin	Lovastatin	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Hydrocortisone	Hydrocortisone	26	16
Eliquis	Apixaban	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Otezla	Apremilast	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Mupirocin	Mupirocin	23	17
Alvesco	Ciclesonide	22	13
Liraglutide	Liraglutide	22	11
Naproxen	Naproxen	22	11
Acetaminophen-Codeine	Acetaminophen With Codeine	21	11
Baclofen	Baclofen	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	11
Clonazepam	Clonazepam	19	suppressed
Ketoconazole	Ketoconazole	19	12
Latanoprost	Latanoprost	19	suppressed
Metronidazole	Metronidazole	19	18
Amoxicillin	Amoxicillin	18	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Colchicine	Colchicine	18	suppressed
Metoprolol Succinate	Metoprolol Succinate	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	11
Glipizide Er	Glipizide	17	suppressed
Testosterone	Testosterone	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	16	11
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Fluconazole	Fluconazole	14	11
Nystatin	Nystatin	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Single Use Swab	Alcohol Antiseptic Pads	14	suppressed
Tacrolimus	Tacrolimus	14	13
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Econazole Nitrate	Econazole Nitrate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error